CHAIR
:
SPEAKER
(S):
Lynn Roy Webster, MD (SPKNON), Medical Director, CRI Lifetree, United States
Jack Henningfield,
PhD (SPKNON), Vice President, Research, Health Policy, and Abuse Liabiliy,
Pinney Associates, United States
Professor Adjunct, Johns Hopkins School of Medicine, past chief Abuse Potential and Clinical Pharmacology, NIDA. 400+ articles and books related to drug abuse & regulation, public health, and neuropharmacology. My PinneyAssociates focus is on drug development, risk management, and regulatory issues.
|
Robert A. Medve, MD (SPKNON), Chief Medical Officer, Nektar Therapeutics, United States
Description
This workshop will address clinical aspects of conducting human abuse liability studies. It will provide insight on FDA's Draft Decision Tree on Assessment of Abuse Potential and the appropriate methodology for assessment of abuse liability potential.
**Due to workshop format, seating will be limited and will be available on a first come, first served basis.
The Boston Convention and Exhibition Center (BCEC) has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this event will not be recorded.